Reporting owner · CIK 0001517775
Lee Willis C
Visual SEC Form 4 history across 1 companies, 6 transactions and 1 filings.
CEOCEOEmmaus Life Sciences, Inc.
Open-market mix
100%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
May 25
$1.4K
Aug 25
$1.7K
Aug 26
$15K
Transaction texture
Ownership and ticket size
Average P/S size$3K
Median P/S size$2.2K
Direct0
Indirect6
Aug 31, 2026buy
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
buy at Emmaus Life Sciences, Inc. on Aug 31, 2026 valued at $5,000.
Review SEC filingLatest sale
No open-market insider sale is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| EMMA | LEE WILLIS C | CEO | buy | 100k | $500k | P | — | 09/02 | 08/31 | |
| EMMA | LEE WILLIS C | CEO | buy | 94.7k | $568k | P | — | 09/02 | 08/28 | |
| EMMA | LEE WILLIS C | CEO | buy | 50.0k | $250k | P | — | 09/02 | 08/27 | |
| EMMA | LEE WILLIS C | CEO | buy | 46.0k | $184k | P | — | 09/02 | 08/25 | |
| EMMA | LEE WILLIS C | CEO | buy | 170k | $170k | P | — | 09/02 | 08/29/2025 | |
| EMMA | LEE WILLIS C | CEO | buy | 70.0k | $140k | P | — | 09/02 | 05/30/2025 |
Lee Willis C Insider Activity FAQ
SEC Form 4 context
Who is Lee Willis C?
Lee Willis C is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001517775.
Which companies has Lee Willis C reported transactions for?
Emmaus Life Sciences, Inc.
When was Lee Willis C's latest insider buy?
buy at Emmaus Life Sciences, Inc. on Aug 31, 2026 valued at $5,000.
When was Lee Willis C's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.